Truffle Capital
Truffle Capital is an independent European private equity firm originally set up for investing in technology spin-offs.
Business Model:
Revenue: $2M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Truffle Capital Information
Geographic Data
Address: 5, rue de la Baume
City: Paris
State: other
Zip: 75008
Country: FR
Financial Info
Stage:
Raised Last:
$0
Raised Total:$536M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
4,450,921Website Global Rank
2,671Website Monthly Traffic
Twitter Followers
Description
Truffle Capital is an independent, European venture capital firm focused on disruptive technologies in IT (FinTech and InsurTech) and Life Sciences (BioTech and MedTech). Truffle Capital aims to support the creation and growth of young innovative companies with the potential to become tomorrow’s market leaders. Chaired by Patrick Kron, alongside the company’s founders and CEOs, Philippe Pouletty and Bernard-Louis Roques, Truffle Capital raised over $1 billion and has supported over 75 companies since its creation, in the digital technologies and life sciences sectors. At the end of 2017, Truffle Capital successfully completed the first close of its two new institutional funds, Truffle Financial Innovation Fund and Truffle BioMedTech Fund, as well as the first close of a fund dedicated to the French Reserve Fund (« Fonds de Réserve pour les Retraites » or « FRF »). On May 2019, Truffle Capital is a company of 24 professionals from various nationalities (French, Italian, English, Chinese…), passionated by the trade of financing innovation.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2011 | Myopowers Medical Technologies | Series B | 16M |
| 6/2015 | Myopowers Medical Technologies | Series C | 5.1M |
| 1/2006 | Deinove SA | Funding Round | - |
| 10/2011 | Biokinesis | Funding Round | - |
| 2/2006 | Cytomics Pharmaceuticals | Series B | 11.9M |
| 1/2008 | CARMAT | Funding Round | - |
| 3/2008 | Eco-Carbone | Private Equity Round | 3.2M |
| 2/2022 | RollingFunds | Venture Round | 0 |
| 9/2011 | Pharnext | Series B | 3.5M |
| 6/2011 | Utel | Venture Round | 4.1M |
| 5/2019 | RollingFunds | Series A | 1.5M |
| 9/2007 | PeopleCube | Venture Round | 17M |
| 6/2005 | Theradiag | Series C | 6.1M |
| 5/2021 | Zaion | Series A | 11M |
| 1/2006 | RF-iT Solutions | Series A | 0 |
| 2/2012 | CoolGames | Venture Round | 2.3M |
| 6/2015 | Actility | Series C | 0 |
| 7/2021 | Monisnap | Series A | 0 |
| 9/2022 | Obat | Seed Round | 0 |
| 7/2020 | WeGroup | Series A | 3.5M |
| 3/2010 | Immune Targeting Systems | Series A | 13.2M |
| 7/2009 | Symetis | Series B | 0 |
| 2/2021 | Smile&a;Pay | Series B | 0 |
| 12/2015 | Geocorail | Venture Round | 2M |
| 7/2022 | Bridge | Series A | 20.3M |
| 2/2012 | Pharnext | Venture Round | 10.6M |
| 5/2003 | Theradiag | Series B | 10.4M |
| 11/2017 | MoneyTrack | Pre Seed Round | - |
| 2/2012 | CoolGames | Funding Round | 2.3M |
| 3/2021 | MoneyTrack | Series A | 2.7M |
| 11/2017 | MoneyTrack | Funding Round | - |
| 10/2012 | Carbios | Funding Round | 4.3M |
| 5/2012 | SP3H | Venture Round | 2.8M |
| 4/2014 | SP3H | Venture Round | 3.4M |
| 2/2021 | Particeep | Secondary Market | 0 |
| 9/2021 | IPaidThat | Venture Round | 0 |
| 4/2019 | IPaidThat | Seed Round | 1.1M |
| 10/2010 | Actility | Seed Round | 4.1M |
| 2/2015 | Altimmune | Post-IPO Equity | 16M |
| 7/2015 | Theraclion | Post-IPO Equity | 250k |
| 1/2005 | AS Group | Private Equity Round | - |
| 2/2018 | Smile&a;Pay | Series A | 3.1M |
| 9/2013 | CoolGames | Series A | 5M |
| 10/2019 | Monisnap | Seed Round | 2.8M |
| 7/2007 | Neovacs | Venture Round | 17.9M |
| 7/2007 | Immune Targeting Systems | Series A | 7.1M |
| 5/2022 | Cachet | Series A | 0 |
| 6/2010 | Pharnext | Series A | 0 |
| 1/2013 | Momac | Series B | 3.9M |
| 9/2022 | Abivax | Post-IPO Equity | 0 |
| 1/2004 | Equitime | Funding Round | - |
| 4/2021 | ACASI | Seed Round | 0 |
| 10/2007 | OSEAD Maroc Mining | Private Equity Round | - |
| 1/2022 | Cake App | Seed Round | 0 |
| 9/2022 | Obat | Seed Round | 0 |
| 9/2022 | Abivax | Post-IPO Equity | 0 |
| 5/2022 | Cachet | Series A | 0 |
| 1/2022 | Cake App | Seed Round | 0 |
| 9/2021 | IPaidThat | Venture Round | 0 |
| 7/2021 | Monisnap | Series A | 0 |
| 5/2021 | Zaion | Series A | 0 |
| 4/2021 | ACASI | Seed Round | 0 |
| 3/2021 | MoneyTrack | Series A | 0 |
| 2/2021 | Smile&a;Pay | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
